DG(18:3(9Z,12Z,15Z)/22:1(13Z)/0:0) (BioCAD00000021193)

blood all tissues

Metabolite Card

Formula: C43H76O5 (672.5692)
SMILES: [H][C@](CO)(COC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC)OC(=O)CCCCCCCCCCC\C=C/CCCCCCCC

Synonyms [en]

1-a-Linolenoyl-2-erucoyl-sn-glycerol; DG(40:4); DG(18:3(9Z,12Z,15Z)/22:1(13Z)/0:0); 1-(9Z,12Z,15Z-octadecatrienoyl)-2-(13Z-docosenoyl)-sn-glycerol; Diacylglycerol(40:4); DG(18:3(9Z,12Z,15Z)/22:1(13Z)/0:0)[iso2]

Reviewed

Last reviewed on 2024-06-28.

Cite this Page

DG(18:3(9Z,12Z,15Z)/22:1(13Z)/0:0). 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China. https://biocad_registry.innovation.ac.cn/s/(-)-arctiin (retrieved 2026-01-03) (CAD Registry RN: BioCAD00000021193). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Note

DG(18:3(9Z,12Z,15Z)/22:1(13Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(18:3(9Z,12Z,15Z)/22:1(13Z)/0:0), in particular, consists of one chain of a-linolenic acid at the C-1 position and one chain of erucic acid at the C-2 position. The a-linolenic acid moiety is derived from seed oils, especially canola and soybean oil, while the erucic acid moiety is derived from seed oils and avocados. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position.

Entity Information

DBLinks

Other DBLinks
  • PubChem: 9543856
  • ChEBI: ChEBI:89235
  • HMDB: HMDB0007319
  • LipidMaps: LMGL02010191
  • Metlin: METLIN_4533
  • Coconut NaturalProduct: CNP0102541.1
  • Coconut NaturalProduct: CNP0102541.2

Class / Ontology

Metabolic Network
ID EC Number Name
View More
Organism Source

Taxonomy Source

Pathway Synthetic

pathway id name
PathBank:SMP0067228 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:1(13Z)/22:2(13Z,16Z))
PathBank:SMP0067232 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0025695 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
PathBank:SMP0025699 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0071541 Phosphatidylethanolamine Biosynthesis PE(18:3(9Z,12Z,15Z)/22:1(13Z))
PathBank:SMP0075976 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:1(13Z)/22:2(13Z,16Z))
PathBank:SMP0075980 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0080686 Phosphatidylcholine Biosynthesis PC(18:3(9Z,12Z,15Z)/22:1(13Z))
PathBank:SMP0013461 Triacylglycerol Degradation TG(18:3(9Z,12Z,15Z)/22:1(13Z)/16:0)
PathBank:SMP0013465 Triacylglycerol Degradation TG(18:3(9Z,12Z,15Z)/22:1(13Z)/18:2(9Z,12Z))
PathBank:SMP0013469 Triacylglycerol Degradation TG(18:3(9Z,12Z,15Z)/22:1(13Z)/20:1(11Z))
PathBank:SMP0091250 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:1(13Z)/22:2(13Z,16Z))
PathBank:SMP0091254 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0067227 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:1(13Z)/22:1(13Z))
PathBank:SMP0067231 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0025694 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:1(13Z)/18:3(9Z,12Z,15Z))
PathBank:SMP0025698 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0075975 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:1(13Z)/22:1(13Z))
PathBank:SMP0075979 De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0013464 Triacylglycerol Degradation TG(18:3(9Z,12Z,15Z)/22:1(13Z)/18:1(11Z))
View All Pathways